Assignee
INST CURIE
FR·51 granted patents·87 pending applications·246 citations·filing 1997–2025
Top patents by PatentIndex Score
138 records- 0187US11285176B2Immune cells defective for Suv39h1INST CURIE·Filed 2021·Granted Mar 29, 2022·1 cites·13 claims
- 0287US7718601B2Shiga toxin B-subunit as a vector for tumor diagnosis and drug delivery to Gb3 expressing tumorsINST CURIE·Filed 2005·Granted May 18, 2010·5 cites·23 claims
- 0386US12371471B2Immune cells defective for SUV39H1INST CURIE·Filed 2024·Granted Jul 29, 2025·0 cites·16 claims
- 0484US7981400B2Shiga toxin B-subunit as a vector for tumor diagnosis and drug delivery to GB3 expressing tumorsINST CURIE·Filed 2010·Granted Jul 19, 2011·5 cites·39 claims
- 0584US7741308B2DBAIT and uses thereofINST CURIE·Filed 2008·Granted Jun 22, 2010·6 cites·23 claims
- 0683US7632514B2Universal carrier for targeting molecules to Gb3 receptor expressing cellsINST CURIE·Filed 2003·Granted Dec 15, 2009·11 cites·11 claims
- 0782US10576103B2Immune cells defective for SUV39H1INST CURIE·Filed 2019·Granted Mar 3, 2020·3 cites·18 claims
- 0882US9347915B2Non-thermosensitive medium for analyzing species in a channel and for minimizing absorption and/or electroosomosic phenomenaINST CURIE·Filed 2015·Granted May 24, 2016·2 cites·1 claims
- 0981US10010607B2Method for preparing viral particles with cyclic dinucleotide and use of said particles for inducing immune responseINST CURIE·Filed 2015·Granted Jul 3, 2018·6 cites·21 claims
- 1081US7476729B2Dbait and uses thereofINST CURIE·Filed 2006·Granted Jan 13, 2009·4 cites·23 claims
- 1180US11622978B2Immune cells defective for SUV39H1INST CURIE·Filed 2020·Granted Apr 11, 2023·1 cites·23 claims
- 1280US6879394B2Multi-photon imaging installationINST CURIE·Filed 2003·Granted Apr 12, 2005·32 cites·51 claims
- 1379US10603265B2Skin whitening peptide agentsINST CURIE·Filed 2015·Granted Mar 31, 2020·3 cites·10 claims
- 1478US2023201264A1Immune cells defective for suv39h1INST CURIE·Filed 2023·Application pending·0 cites
- 1577US11162095B2Use of a combination of Dbait molecule and PARP inhibitors to treat cancerINST CURIE·Filed 2020·Granted Nov 2, 2021·1 cites·16 claims
- 1677US10661278B2Device for manipulation of packets in micro-containers, in particular in microchannelsINST CURIE·Filed 2016·Granted May 26, 2020·1 cites·13 claims
- 1777US2024216388A1Inhibitor of suv39h1 histone methyltransferase for use in cancer combination therapyINST CURIE·Filed 2024·Application pending·0 cites
- 1876US9658189B2Non-thermosensitive medium for analyzing species in a channel and for minimizing adsorption and/or electroosomosic phenomenaINST CURIE·Filed 2016·Granted May 23, 2017·1 cites·28 claims
- 1974US7115608B2Pyridinone and pyridinethione derivatives having HIV inhibiting propertiesINST CURIE·Filed 2001·Granted Oct 3, 2006·8 cites·9 claims
- 2072US7279334B2Methods for inducing targeted stimulation of meiotic recombination and kits for performing said methodsINST CURIE·Filed 2005·Granted Oct 9, 2007·4 cites·22 claims
- 2171US10563197B2Use of a combination of Dbait molecule and PARP inhibitors to treat cancerINST CURIE·Filed 2016·Granted Feb 18, 2020·1 cites·26 claims
- 2271US7595302B2Nucleic acids useful for triggering tumor cell lethalityINST CURIE·Filed 2004·Granted Sep 29, 2009·5 cites·22 claims
- 2371US6830670B1Heat-sensitive medium for separating species in a separating channel and use thereofINST CURIE·Filed 1999·Granted Dec 14, 2004·43 cites·33 claims
- 2470US6862923B2Atomic force microscopeINST CURIE·Filed 2001·Granted Mar 8, 2005·31 cites·15 claims
- 2569US12371741B2Method for detecting a mutation in a microsatellite sequenceINST CURIE·Filed 2024·Granted Jul 29, 2025·0 cites·9 claims
- 2669US2024247318A1Methods for detecting inactivation of the homologous recombination pathway (brca1/2) in human tumorsINST CURIE·Filed 2024·Application pending·0 cites
- 2768US11097275B2Device for manipulation of packets in micro-containers, in particular in microchannelsINST CURIE·Filed 2020·Granted Aug 24, 2021·0 cites·13 claims
- 2868US9603923B2Universal carrier for targeting molecules to GB3 receptor expressing cellsINST CURIE·Filed 2014·Granted Mar 28, 2017·0 cites·11 claims
- 2968US9469840B2Device for guiding cell migration and method of guiding cell migration implementing such a deviceINST CURIE·Filed 2012·Granted Oct 18, 2016·1 cites·33 claims
- 3068US2019204266A1Non-thermosensitive medium for analyzing species in a channel and for minimizing adsorption and/or electroosomosic phenomenaINST CURIE·Filed 2018·Application pending·0 cites
- 3167US12252517B2Hook fusion protein for regulating the cellular trafficking of a target proteinINST CURIE·Filed 2023·Granted Mar 18, 2025·0 cites·9 claims
- 3266US2025213614A1Modified RELA Protein for Inducing Interferon Expression and Engineered Immune Cells with Improved Interferon ExpressionINST CURIE·Filed 2023·Application pending·0 cites
- 3366US2026008748A1Compounds with biguanidyl radical and uses thereofINST CURIE·Filed 2025·Application pending·0 cites
- 3466US2025241949A1Myeloid cells modified by chimeric antigen receptor and uses thereof for anti-cancer therapyINST CURIE·Filed 2023·Application pending·0 cites
- 3565US2025163113A1PEPTIDES TARGETING THE INTERACTION BETWEEN KINDLIN-1 AND Beta-INTEGRININST CURIE·Filed 2023·Application pending·0 cites
- 3664US2024101616A1Dap10/12 based cars adapted for rushINST CURIE·Filed 2023·Application pending·0 cites
- 3763US12152077B1Immunotherapy targeting tumor neoantigenic peptidesINST CURIE·Filed 2023·Granted Nov 26, 2024·0 cites·9 claims
- 3863US2025222106A1Myeloid cells modified by chimeric antigen receptor with cd40 and uses thereof for anti-cancer therapyINST CURIE·Filed 2023·Application pending·0 cites
- 3963US2018024095A1Non-thermosensitive medium for analyzing species in a channel and for minimizing adsorption and/or electroosomosic phenomenaINST CURIE·Filed 2017·Application pending·0 cites
- 4062US2025170422A1Device, apparatus and method for minibeam radiation therapyINST CURIE·Filed 2024·Application pending·0 cites
- 4162US2025304915A1Myeloid Cells Overexpressing BCL2INST CURIE·Filed 2022·Application pending·0 cites
- 4261US2011190627A1Method and Device for Marking a Medium, and Marker Usable in Such a MethodINST CURIE·Filed 2009·Application pending·0 cites
- 4361US2025302930A1Immunotherapy targeting tumor transposable element derived neoantigenic peptides in glioblastomaINST CURIE·Filed 2023·Application pending·0 cites
- 4461US2026048106A1Immunotherapy targeting tumor transposable element derivedneoantigenic peptides in glioblastomaINST CURIE·Filed 2025·Application pending·0 cites
- 4561US2024423927A1Compositions and methods for use in immunotherapyINST CURIE·Filed 2022·Application pending·0 cites
- 4661US2024269282A1Methods for the Treatment of Cancer, Inflammatory Diseases and Autoimmune DiseasesINST CURIE·Filed 2022·Application pending·0 cites
- 4760US7371742B2Porphyrin derivatives for photodynamic therapyINST CURIE·Filed 2002·Granted May 13, 2008·3 cites·17 claims
- 4860US2020157225A1Inhibitor of suv39h1 histone methyltransferase for use in cancer combination therapyINST CURIE·Filed 2020·Application pending·0 cites
- 4960US2020147099A1Inhibitor of suv39h1 histone methyltransferase for use in cancer combination therapyINST CURIE·Filed 2018·Application pending·0 cites
- 5060US2023117652A1Method for Detecting a Mutation in a Microsatellite SequenceINST CURIE·Filed 2022·Application pending·0 cites
Showing the top 50 of 138 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when INST CURIE files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →